| Primary |
| Renal Transplant |
13.1% |
| Immunosuppression |
10.4% |
| Diffuse Large B-cell Lymphoma |
7.1% |
| Acute Lymphocytic Leukaemia |
7.0% |
| Rheumatoid Arthritis |
6.1% |
| Asthma |
5.8% |
| Prostate Cancer |
4.6% |
| Hodgkin's Disease |
4.5% |
| Non-hodgkin's Lymphoma |
4.4% |
| Multiple Myeloma |
4.1% |
| Drug Use For Unknown Indication |
3.9% |
| Prophylaxis Against Transplant Rejection |
3.7% |
| Systemic Lupus Erythematosus |
3.7% |
| Immunosuppressant Drug Therapy |
3.6% |
| Product Used For Unknown Indication |
3.4% |
| Lung Transplant |
3.1% |
| Crohn's Disease |
2.9% |
| Hypertension |
2.9% |
| Prostate Cancer Metastatic |
2.9% |
| Liver Transplant |
2.8% |
|
| Weight Increased |
10.1% |
| Pneumonia |
8.8% |
| Weight Decreased |
8.3% |
| Osteonecrosis |
7.0% |
| Drug Ineffective |
6.6% |
| Lymphoproliferative Disorder |
6.1% |
| Squamous Cell Carcinoma |
5.3% |
| Respiratory Failure |
4.8% |
| Renal Failure |
4.4% |
| Thrombocytopenia |
4.4% |
| Vision Blurred |
4.4% |
| Vomiting |
4.4% |
| Hyperglycaemia |
3.9% |
| Medication Error |
3.9% |
| Pyrexia |
3.5% |
| Blood Glucose Increased |
3.1% |
| Death |
3.1% |
| Basal Cell Carcinoma |
2.6% |
| Chronic Myeloid Leukaemia |
2.6% |
| Condition Aggravated |
2.6% |
|
| Secondary |
| Diffuse Large B-cell Lymphoma |
26.8% |
| Drug Use For Unknown Indication |
16.1% |
| Product Used For Unknown Indication |
6.6% |
| Multiple Myeloma |
6.0% |
| B-cell Lymphoma |
4.6% |
| Rheumatoid Arthritis |
4.5% |
| Acute Lymphocytic Leukaemia |
4.0% |
| Non-hodgkin's Lymphoma |
3.9% |
| Prophylaxis Against Transplant Rejection |
3.4% |
| Renal Transplant |
3.3% |
| Hodgkin's Disease |
3.2% |
| Prophylaxis |
3.0% |
| Prostate Cancer |
2.7% |
| Hypertension |
2.5% |
| Lymphoma |
1.8% |
| Pain |
1.6% |
| Prostate Cancer Metastatic |
1.6% |
| Crohn's Disease |
1.5% |
| Peripheral T-cell Lymphoma Unspecified |
1.3% |
| Burkitt's Lymphoma |
1.3% |
|
| Febrile Neutropenia |
12.3% |
| Pyrexia |
7.5% |
| Pneumonia |
7.4% |
| Vomiting |
6.1% |
| Neutropenia |
5.4% |
| Sepsis |
5.4% |
| Osteonecrosis |
5.2% |
| Upper Respiratory Tract Infection |
5.1% |
| Weight Decreased |
5.1% |
| White Blood Cell Count Decreased |
4.8% |
| Death |
4.8% |
| Weight Increased |
4.3% |
| Thrombocytopenia |
3.9% |
| Myelodysplastic Syndrome |
3.5% |
| Progressive Multifocal Leukoencephalopathy |
3.5% |
| Pneumocystis Jiroveci Pneumonia |
3.4% |
| Pulmonary Embolism |
3.2% |
| Septic Shock |
3.2% |
| Urinary Tract Infection |
3.0% |
| Transplant Rejection |
3.0% |
|
| Concomitant |
| Drug Use For Unknown Indication |
21.9% |
| Product Used For Unknown Indication |
19.6% |
| Rheumatoid Arthritis |
18.8% |
| Crohn's Disease |
8.0% |
| Hypertension |
4.0% |
| Pain |
3.9% |
| Asthma |
2.9% |
| Osteoporosis |
2.1% |
| Multiple Myeloma |
2.1% |
| Depression |
1.8% |
| Renal Transplant |
1.8% |
| Vitamin Supplementation |
1.8% |
| Chronic Obstructive Pulmonary Disease |
1.8% |
| Prophylaxis |
1.7% |
| Colitis Ulcerative |
1.7% |
| Gastrooesophageal Reflux Disease |
1.3% |
| Diabetes Mellitus |
1.3% |
| Prophylaxis Against Transplant Rejection |
1.3% |
| Premedication |
1.2% |
| Anxiety |
1.1% |
|
| Vomiting |
11.8% |
| Weight Decreased |
8.8% |
| Pneumonia |
6.3% |
| Pyrexia |
6.2% |
| Injection Site Pain |
5.7% |
| Drug Ineffective |
5.6% |
| Death |
5.4% |
| Pain |
4.9% |
| Urinary Tract Infection |
4.7% |
| Weight Increased |
4.6% |
| Crohn's Disease |
4.5% |
| Nausea |
3.9% |
| Dyspnoea |
3.8% |
| Pulmonary Embolism |
3.8% |
| Rash |
3.7% |
| Sepsis |
3.5% |
| Fatigue |
3.4% |
| Thrombocytopenia |
3.4% |
| Urticaria |
3.3% |
| Diarrhoea |
3.1% |
|
| Interacting |
| Drug Use For Unknown Indication |
28.5% |
| Product Used For Unknown Indication |
23.2% |
| Rheumatoid Arthritis |
8.7% |
| Asthma |
7.0% |
| Diffuse Large B-cell Lymphoma |
4.7% |
| Rhinitis Allergic |
4.0% |
| Renal Transplant |
3.0% |
| Gastrooesophageal Reflux Disease |
2.7% |
| Sinusitis |
2.7% |
| Hiv Infection |
2.0% |
| Atrial Fibrillation |
1.7% |
| Lymphoma |
1.7% |
| Arrhythmia |
1.3% |
| Blood Pressure |
1.3% |
| Bone Disorder |
1.3% |
| Hodgkin's Disease |
1.3% |
| Insomnia |
1.3% |
| Multiple Myeloma |
1.3% |
| Hypersensitivity |
1.0% |
| Lung Infection |
1.0% |
|
| Drug Interaction |
28.6% |
| Upper Respiratory Tract Infection |
9.5% |
| Tachycardia |
7.1% |
| Transplant Rejection |
7.1% |
| Hepatic Enzyme Increased |
4.8% |
| Resorption Bone Increased |
4.8% |
| Rhabdomyolysis |
4.8% |
| Swelling |
4.8% |
| Agranulocytosis |
2.4% |
| Bladder Cancer |
2.4% |
| Central Nervous System Lymphoma |
2.4% |
| Dizziness |
2.4% |
| Drug Ineffective |
2.4% |
| Duodenal Ulcer |
2.4% |
| Ear Disorder |
2.4% |
| Eye Infection Toxoplasmal |
2.4% |
| Fat Embolism |
2.4% |
| Haemorrhoids |
2.4% |
| Herpes Zoster |
2.4% |
| Hypocalcaemia |
2.4% |
|
